KLOW is a 4-in-1 peptide blend formulated with BPC-157, TB-500, GHK-Cu, and KPV. BPC-157 is a peptide associated with the body’s natural repair processes, particularly in tissues under physical stress. TB-500 is a synthetic peptide linked to pathways involved in healing response and recovery. KPV is a tripeptide researched for its role in inflammatory signaling and barrier tissue health. GHK-Cu is a naturally occurring copper peptide known for its involvement in collagen production and skin-related repair processes. Together, these peptides work across complementary pathways involved in repair, inflammation, circulation, and skin and gut health.

These peptides are being explored for their role in supporting biological processes involved in tissue repair, inflammatory balance, and skin and gut health. It may be of interest to individuals focused on maintaining recovery, resilience, and overall tissue function as part of a broader wellness approach.

Disclaimer: This information reflects findings from preclinical and observational research. Clinical safety and efficacy in humans have not been established.

Each order includes two 5 mL vials of KLOW. Dosing is determined by your licensed provider based on your individual health profile and treatment goals. Based on typical prescribing patterns, two vials are designed to last approximately 2 months. Please follow the dosing instructions provided by your healthcare provider to ensure safe and appropriate use.

Treatment protocols for KLOW are determined by the prescribing clinician based on an individual patient’s health history, goals, and clinical assessment. A commonly used protocol involves administration five times per week for approximately eight weeks, followed by a two-week break before repeating the cycle, if appropriate.

Vials should be refrigerated immediately after arrival to maintain quality. The vial should be stored at 2-8°C (36-46°F). Please keep the vial away from sunlight and avoid shaking it.

While BPC-157, TB-500, KPV, and GHK-Cu injections have not been studied for safety and efficacy in large-scale human clinical trials, some risks may be hypothesized from their mechanisms of action. These can include injection site irritation, headache, flushing or warmth, fatigue, mild gastrointestinal discomfort such as nausea, dizziness, or changes in appetite.

Disclaimer: Comprehensive human safety data for these peptides are limited. The side effects listed reflect available literature and research but may not represent all potential reactions.

Yes. Even though your prescription is reviewed by a licensed provider, you should inform your primary care physician that you are using BPC-157/TB-500/GHK-Cu/KPV. Your primary provider has a comprehensive understanding of your medical history and can help ensure coordinated, safe care.